Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 19Lung Neoplasms 16Prostatic Neoplasms 12Colorectal Neoplasms 12Hematologic Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 6Neoplasms 5Neoplasm Metastasis 5Lymphoma 5Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Melanoma 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Fatigue 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Uterine Cervical Neoplasms 2Skin Carcinoma 2Papillomavirus Infections 2Malignant Solid Neoplasm 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphoid System Neoplasm 2Healthy Subject 2Genital Neoplasms, Female 2Gastrointestinal Neoplasms 2

Interventions

pembrolizumab 69Nivolumab 67cabozantinib 45Ipilimumab 36Specimen Handling 32Magnetic Resonance Spectroscopy 32lenvatinib 26Axitinib 25belzutifan 21Sunitinib 17Biopsy 15Radiosurgery 14CTLA-4 Antigen 13atezolizumab 12Everolimus 10pazopanib 8fludarabine 8avelumab 8Bevacizumab 8toripalimab 7cemiplimab 7Nephrectomy 7Immunoglobulin G 7Cyclophosphamide 7aldesleukin 6Standard of Care 6Radiotherapy 6Blood Specimen Collection 6spartalizumab 5palbociclib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Educational Status × 1 year × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡